APA (7th ed.) Citation

C, H., K, A., L, H., C, A., D, L., L, P., . . . A, P. (2024). The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19. IScience, 28(2), 111698. https://doi.org/10.1016/j.isci.2024.111698

Chicago Style (17th ed.) Citation

C, Hernández-Blanco, et al. "The Phase I RELEASE Clinical Trial to Evaluate the Safety of NK Cells in COVID-19." IScience 28, no. 2 (2024): 111698. https://doi.org/10.1016/j.isci.2024.111698.

MLA (9th ed.) Citation

C, Hernández-Blanco, et al. "The Phase I RELEASE Clinical Trial to Evaluate the Safety of NK Cells in COVID-19." IScience, vol. 28, no. 2, 2024, p. 111698, https://doi.org/10.1016/j.isci.2024.111698.